http://www.xconomy.com/seattle/2009/04/06/seattle-genetics-gets-4m-from-millennium/ Business + Technology in the Exponential Economy Sat, 11 Feb 2012 03:54:18 +0000 hourly 1 http://wordpress.org/?v=3.0.4 http://www.xconomy.com/seattle/2009/04/06/seattle-genetics-gets-4m-from-millennium/comment-page-1/#comment-53348 Antibody Industry Week in Review | 4.13.09 — The Antibody Blog Mon, 13 Apr 2009 05:10:14 +0000 http://www.xconomy.com/?p=19195#comment-53348 [...] Genetics and Millennium (Takeda) have entered into an agreement for the development of antibody-drug conjugates (ADCs).  Millennium will pay a $4M upfront fee for [...] [...] Genetics and Millennium (Takeda) have entered into an agreement for the development of antibody-drug conjugates (ADCs).  Millennium will pay a $4M upfront fee for [...]

]]>